600252 中恒集团
已收盘 05-14 15:00:00
资讯
新帖
简况
股市必读:中恒集团一季报 - 第一季度单季净利润同比下降292.41%
证券之星 · 05-06
股市必读:中恒集团一季报 - 第一季度单季净利润同比下降292.41%
每周股票复盘:中恒集团(600252)一季度净亏损3353万
证券之星 · 05-02
每周股票复盘:中恒集团(600252)一季度净亏损3353万
中恒集团(600252)3月31日股东户数11.9万户,较上期增加0.16%
证券之星 · 04-30
中恒集团(600252)3月31日股东户数11.9万户,较上期增加0.16%
图解中恒集团一季报:第一季度单季净利润同比下降292.41%
证券之星 · 04-30
图解中恒集团一季报:第一季度单季净利润同比下降292.41%
每周股票复盘:中恒集团(600252)完成力合中恒医药基金清算注销
证券之星 · 04-26
每周股票复盘:中恒集团(600252)完成力合中恒医药基金清算注销
中恒集团(600252)披露广西力合中恒医药投资合伙企业完成清算注销公告,4月23日股价下跌0.8%
证券之星 · 04-23
中恒集团(600252)披露广西力合中恒医药投资合伙企业完成清算注销公告,4月23日股价下跌0.8%
每周股票复盘:中恒集团(600252)2025年亏损3.57亿
证券之星 · 04-19
每周股票复盘:中恒集团(600252)2025年亏损3.57亿
中恒集团(600252)披露广投金控免于发出要约收购之2025年度持续督导意见,4月16日股价下跌2.64%
证券之星 · 04-16
中恒集团(600252)披露广投金控免于发出要约收购之2025年度持续督导意见,4月16日股价下跌2.64%
图解中恒集团年报:第四季度单季净利润同比增长1.97%
证券之星 · 03-31
图解中恒集团年报:第四季度单季净利润同比增长1.97%
每周股票复盘:中恒集团(600252)控股子公司药品通过一致性评价
证券之星 · 03-29
每周股票复盘:中恒集团(600252)控股子公司药品通过一致性评价
中恒集团(600252)披露控股子公司注射用氨曲南通过一致性评价,3月24日股价上涨3.9%
证券之星 · 03-24
中恒集团(600252)披露控股子公司注射用氨曲南通过一致性评价,3月24日股价上涨3.9%
中恒集团最新公告:控股子公司获得药品补充申请批准通知书
证券之星 · 03-24
中恒集团最新公告:控股子公司获得药品补充申请批准通知书
中恒集团(600252)披露前期会计差错更正及追溯调整公告,3月23日股价下跌6.85%
证券之星 · 03-23
中恒集团(600252)披露前期会计差错更正及追溯调整公告,3月23日股价下跌6.85%
每周股票复盘:中恒集团(600252)更正前期差错调减营收
证券之星 · 03-22
每周股票复盘:中恒集团(600252)更正前期差错调减营收
每周股票复盘:中恒集团(600252)莱美药业拟投500万设生物医药基金
证券之星 · 03-15
每周股票复盘:中恒集团(600252)莱美药业拟投500万设生物医药基金
中恒集团(600252)披露公司董事辞职公告,3月13日股价下跌0.38%
证券之星 · 03-13
中恒集团(600252)披露公司董事辞职公告,3月13日股价下跌0.38%
中恒集团最新公告:董事刘龙因工作安排原因辞职
证券之星 · 03-13
中恒集团最新公告:董事刘龙因工作安排原因辞职
中恒集团(600252.SH)控股子公司拟出资500万元参与设立创业投资基金
智通财经 · 03-12
中恒集团(600252.SH)控股子公司拟出资500万元参与设立创业投资基金
每周股票复盘:中恒集团(600252)聘任蒋梅芳为副总经理
证券之星 · 03-08
每周股票复盘:中恒集团(600252)聘任蒋梅芳为副总经理
中恒集团(600252)披露聘任公司副总经理公告,3月2日股价下跌1.91%
证券之星 · 03-02
中恒集团(600252)披露聘任公司副总经理公告,3月2日股价下跌1.91%
加载更多
公司概况
公司名称:
广西梧州中恒集团股份有限公司
所属行业:
医药制造业
上市日期:
2000-11-30
主营业务:
广西梧州中恒集团股份有限公司的主营业务是医药制造。公司的主要产品是心脑血管领域用药、骨骼肌肉领域用药、其他普药系列、特色专科类、大输液类、抗感染类、其他品种、药品销售服务、医药流通类、龟苓膏系列、龟苓宝系列、其他食品系列。公司荣获华夏医学科学技术奖科技进步奖三等奖、中国中西医结合学会科学技术奖三等奖、广西科技进步奖二等奖各1项,培育1家广西“专精特新”企业,研发综合实力再提升。
发行价格:
5.25
{"stockData":{"symbol":"600252","market":"SH","secType":"STK","nameCN":"中恒集团","latestPrice":2.31,"timestamp":1778742001000,"preClose":2.35,"halted":0,"volume":44886100,"delay":0,"changeRate":-0.017,"floatShares":3184000000,"shares":3184000000,"eps":-0.1282,"marketStatus":"已收盘","change":-0.04,"latestTime":"05-14 15:00:00","open":2.35,"high":2.36,"low":2.3,"amount":104000000,"amplitude":0.0255,"askPrice":2.32,"askSize":15667,"bidPrice":2.31,"bidSize":383,"shortable":0,"etf":0,"ttmEps":-0.1282,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1778808600000},"marketStatusCode":5,"adr":0,"adjPreClose":2.35,"symbolType":"stock","openAndCloseTimeList":[[1778722200000,1778729400000],[1778734800000,1778742000000]],"highLimit":2.59,"lowLimit":2.12,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":3184163070,"isCdr":false,"pbRate":1.4,"roa":"--","roe":"--","epsLYR":-0.1144,"committee":0.117557,"marketValue":7355000000,"turnoverRate":0.0141,"status":1,"floatMarketCap":7355000000},"requestUrl":"/m/hq/s/600252","defaultTab":"news","newsList":[{"id":"2633925538","title":"股市必读:中恒集团一季报 - 第一季度单季净利润同比下降292.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633925538","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633925538?lang=zh_cn&edition=full","pubTime":"2026-05-06 03:54","pubTimestamp":1778010851,"startTime":"0","endTime":"0","summary":"来自股本股东变化:截至2026年3月31日,中恒集团股东户数为11.9万户,较2月28日增加194.0户。来自业绩披露要点:中恒集团2026年一季度归母净利润为-3353.06万元,同比下降292.41%。股本股东变化股东户数变动截至2026年3月31日,中恒集团股东户数为11.9万户,较2月28日增加194.0户,增幅0.16%;户均持股数量由上期的2.68万股减少至2.68万股,户均持股市值为6.83万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600003263.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600252"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632647904","title":"每周股票复盘:中恒集团(600252)一季度净亏损3353万","url":"https://stock-news.laohu8.com/highlight/detail?id=2632647904","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632647904?lang=zh_cn&edition=full","pubTime":"2026-05-02 04:23","pubTimestamp":1777666989,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,中恒集团报收于2.46元,较上周的2.48元下跌0.81%。本周,中恒集团4月29日盘中最高价报2.51元。本周关注点业绩披露要点:中恒集团2026年一季报显示归母净利润-3353.06万元,同比下降292.41%。股本股东变化股东户数变动截至2026年3月31日,中恒集团股东户数为11.9万户,较2月28日增加194.0户,增幅0.16%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200002718.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0015","BK0028","BK0077","BK0012","600252","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631131681","title":"中恒集团(600252)3月31日股东户数11.9万户,较上期增加0.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631131681","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631131681?lang=zh_cn&edition=full","pubTime":"2026-04-30 17:23","pubTimestamp":1777540985,"startTime":"0","endTime":"0","summary":"证券之星消息,近日中恒集团披露,截至2026年3月31日公司股东户数为11.9万户,较2月28日增加194.0户,增幅为0.16%。在中药行业个股中,中恒集团股东户数高于行业平均水平,截至3月31日,中药行业平均股东户数为5.39万户。从股价来看,2026年2月28日至2026年3月31日,中恒集团区间跌幅为2.67%,在此期间股东户数增加194.0户,增幅为0.16%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000055496.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","BK0015","BK0188","BK0239","BK0077","600252"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631540439","title":"图解中恒集团一季报:第一季度单季净利润同比下降292.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631540439","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631540439?lang=zh_cn&edition=full","pubTime":"2026-04-30 02:43","pubTimestamp":1777488192,"startTime":"0","endTime":"0","summary":"证券之星消息,中恒集团2026年一季报显示,一季度公司主营收入3.55亿元,同比下降31.94%;归母净利润-3353.06万元,同比下降292.41%;扣非净利润-2111.01万元,同比下降241.38%;负债率35.52%,投资收益-1248.69万元,财务费用812.18万元,毛利率52.85%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000007875.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600252"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630430804","title":"每周股票复盘:中恒集团(600252)完成力合中恒医药基金清算注销","url":"https://stock-news.laohu8.com/highlight/detail?id=2630430804","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630430804?lang=zh_cn&edition=full","pubTime":"2026-04-26 04:03","pubTimestamp":1777147395,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘,中恒集团报收于2.48元,较上周的2.51元下跌1.2%。本周,中恒集团4月21日盘中最高价报2.53元。中恒集团当前最新总市值78.97亿元,在中药板块市值排名29/66,在两市A股市值排名2464/5200。本周关注点公司公告汇总:广西力合中恒医药投资合伙企业完成清算注销,中恒集团实缴出资2,000.00万元已全部收回。由于基金未开展项目投资,经全体合伙人同意,公司于2025年12月启动清算注销程序。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600001723.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","600252","160635","BK0239","BK0012","BK0015","BK0188","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629188247","title":"中恒集团(600252)披露广西力合中恒医药投资合伙企业完成清算注销公告,4月23日股价下跌0.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629188247","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629188247?lang=zh_cn&edition=full","pubTime":"2026-04-23 17:55","pubTimestamp":1776938129,"startTime":"0","endTime":"0","summary":"截至2026年4月23日收盘,中恒集团报收于2.48元,较前一交易日下跌0.8%,最新总市值为78.97亿元。该股当日开盘2.51元,最高2.51元,最低2.46元,成交额达5628.1万元,换手率为0.71%。公告显示,公司于2021年6月决定参与投资设立广西力合中恒医药投资合伙企业,认缴出资29,700.00万元,实缴出资2,000.00万元。由于基金未开展项目投资,经全体合伙人同意,公司于2025年12月启动清算注销程序。本次清算注销不会对公司财务状况和日常经营产生实质性影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300049472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600252","BK0188","BK0239","BK1161","BK0077","BK0028","159938","BK1515","BK1574","09939","BK0015","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628751592","title":"每周股票复盘:中恒集团(600252)2025年亏损3.57亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2628751592","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628751592?lang=zh_cn&edition=full","pubTime":"2026-04-19 03:40","pubTimestamp":1776541217,"startTime":"0","endTime":"0","summary":"截至2026年4月17日收盘,中恒集团报收于2.51元,较上周的2.59元下跌3.09%。本次收购涉及广投集团以其持有的中恒集团859,343,587股股份对广投金控增资,股份已于2025年10月31日完成过户登记,控股股东由广投集团变更为广投金控,实际控制人未变。2025年公司实现营业收入17.49亿元,归母净利润亏损3.57亿元,资产总额100.67亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041900001275.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","BK0015","BK0188","BK0239","BK0077","600252"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627035295","title":"中恒集团(600252)披露广投金控免于发出要约收购之2025年度持续督导意见,4月16日股价下跌2.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627035295","media":"证券之星","labels":["policyRegulatory","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627035295?lang=zh_cn&edition=full","pubTime":"2026-04-16 17:28","pubTimestamp":1776331716,"startTime":"0","endTime":"0","summary":"截至2026年4月16日收盘,中恒集团报收于2.58元,较前一交易日下跌2.64%,最新总市值为82.15亿元。公告显示,国海证券作为财务顾问,出具了关于广投金控及其一致行动人免于发出要约收购中恒集团的2025年度持续督导意见。本次收购涉及广投集团以其持有的中恒集团859,343,587股股份对广投金控增资,股份已于2025年10月31日完成过户登记,控股股东由广投集团变更为广投金控,实际控制人未变。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041600031638.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0015","BK0188","600252","BK0012","BK0028","BK0077","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623325650","title":"图解中恒集团年报:第四季度单季净利润同比增长1.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623325650","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623325650?lang=zh_cn&edition=full","pubTime":"2026-03-31 02:55","pubTimestamp":1774896919,"startTime":"0","endTime":"0","summary":"证券之星消息,中恒集团2025年年报显示,当年度公司主营收入17.49亿元,同比下降16.92%;归母净利润-3.57亿元,同比上升5.28%;扣非净利润-3.07亿元,同比上升7.14%;其中2025年第四季度,公司单季度主营收入3.03亿元,同比上升4.58%;单季度归母净利润-3.81亿元,同比上升1.97%;单季度扣非净利润-3.12亿元,同比上升2.34%;负债率33.01%,投资收益3030.05万元,财务费用-3970.56万元,毛利率44.1%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033100006560.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600252"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623302338","title":"每周股票复盘:中恒集团(600252)控股子公司药品通过一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2623302338","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623302338?lang=zh_cn&edition=full","pubTime":"2026-03-29 03:02","pubTimestamp":1774724536,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘,中恒集团报收于2.51元,较上周的2.48元上涨1.21%。本周,中恒集团3月27日盘中最高价报2.52元。中恒集团当前最新总市值79.92亿元,在中药板块市值排名28/67,在两市A股市值排名2344/5191。有效期为12个月,药品上市许可持有人应在批准之日起6个月内实施变更。注射用氨曲南适用于治疗敏感革兰氏阴性菌引起的多种感染。截至目前,国内已有13家企业通过该药品的一致性评价。莱美药业对该产品的研发总投入为642.01万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900000613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0015","BK0012","BK0239","600252","BK0028","BK0077","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621093042","title":"中恒集团(600252)披露控股子公司注射用氨曲南通过一致性评价,3月24日股价上涨3.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621093042","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621093042?lang=zh_cn&edition=full","pubTime":"2026-03-24 22:26","pubTimestamp":1774362384,"startTime":"0","endTime":"0","summary":"近日,广西梧州中恒集团股份有限公司披露公告,其控股子公司重庆莱美药业股份有限公司收到国家药品监督管理局核准签发的注射用氨曲南《药品补充申请批准通知书》,该药品通过仿制药质量和疗效一致性评价,并获准变更注册标准、直接接触药品的包装材料和容器、有效期和贮藏条件。注射用氨曲南适用于治疗敏感革兰氏阴性菌引起的多种感染。截至目前,国内已有13家企业通过该药品的一致性评价。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400040003.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0015","BK0012","BK0188","600252","BK0239","BK0077","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621063326","title":"中恒集团最新公告:控股子公司获得药品补充申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2621063326","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621063326?lang=zh_cn&edition=full","pubTime":"2026-03-24 17:49","pubTimestamp":1774345785,"startTime":"0","endTime":"0","summary":"中恒集团公告称,公司控股子公司重庆莱美药业股份有限公司收到国家药监局核准签发的注射用氨曲南《药品补充申请批准通知书》,该产品已通过仿制药质量和疗效一致性评价,并同意变更注册标准、直接接触药品的包装材料和容器、有效期及贮藏条件。截至2025年三季度末,该药品在中国医院市场近三年销售额分别为2.59亿元、2.20亿元、0.53亿元。此次获批有助于提升产品市场竞争力,但受政策、招标及市场环境等因素影响,销售存在不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400030342.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0012","BK0188","BK0015","BK0239","600252","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621745417","title":"中恒集团(600252)披露前期会计差错更正及追溯调整公告,3月23日股价下跌6.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621745417","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621745417?lang=zh_cn&edition=full","pubTime":"2026-03-23 17:56","pubTimestamp":1774259765,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘,中恒集团报收于2.31元,较前一交易日下跌6.85%,最新总市值为73.55亿元。该股当日开盘2.46元,最高2.46元,最低2.3元,成交额达1.78亿元,换手率为2.35%。近日,中恒集团发布《关于前期会计差错更正及追溯调整的公告》。公司已于2026年3月20日召开董事会审议通过该事项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300028278.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600252","BK0188","BK0239","BK0077","BK0028","BK0015","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621227796","title":"每周股票复盘:中恒集团(600252)更正前期差错调减营收","url":"https://stock-news.laohu8.com/highlight/detail?id=2621227796","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621227796?lang=zh_cn&edition=full","pubTime":"2026-03-22 02:22","pubTimestamp":1774117332,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘,中恒集团报收于2.48元,较上周的2.62元下跌5.34%。公司公告汇总:中恒集团更正前期会计差错,调减2023-2025年前三季度营收合计超8亿元。中恒集团对2023年至2025年前三季度的会计差错进行更正,主要涉及部分业务收入确认方法由总额法改为净额法,以及部分不满足收入确认条件的业务不再确认收入。业绩披露要点中恒集团追溯调整后的财务报表显示,2025年前三季度因会计差错更正调减营业收入502,841,697.92元、营业成本501,006,086.16元、净利润1,835,611.76元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200000561.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600252"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619178278","title":"每周股票复盘:中恒集团(600252)莱美药业拟投500万设生物医药基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2619178278","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619178278?lang=zh_cn&edition=full","pubTime":"2026-03-15 03:10","pubTimestamp":1773515421,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘,中恒集团报收于2.62元,较上周的2.57元上涨1.95%。本周,中恒集团3月12日盘中最高价报2.65元。广西梧州中恒集团股份有限公司董事会于2026年3月13日收到董事刘龙先生的辞职报告,因其工作安排原因,辞去公司董事及董事会相关专门委员会委员职务,辞职后不再担任公司任何职务。辞职报告自送达董事会之日起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031500000952.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300006","BK0012","BK0070","BK0077","BK0015","160635","BK0028","600252","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619411578","title":"中恒集团(600252)披露公司董事辞职公告,3月13日股价下跌0.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619411578","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619411578?lang=zh_cn&edition=full","pubTime":"2026-03-13 22:52","pubTimestamp":1773413535,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘,中恒集团报收于2.62元,较前一交易日下跌0.38%,最新总市值为83.43亿元。该股当日开盘2.62元,最高2.65元,最低2.6元,成交额达1.33亿元,换手率为1.59%。公告显示,公司董事会于2026年3月13日收到董事刘龙先生的辞职报告,因其工作安排原因,辞去公司董事及董事会相关专门委员会委员职务,辞职后不再担任公司任何职务。辞职报告自送达董事会之日起生效。刘龙先生未持有公司股份,不存在未履行的公开承诺,与董事会无意见分歧。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300042029.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600252","BK0239","BK0077","BK0012","BK0028","BK0188","BK0015"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619196446","title":"中恒集团最新公告:董事刘龙因工作安排原因辞职","url":"https://stock-news.laohu8.com/highlight/detail?id=2619196446","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619196446?lang=zh_cn&edition=full","pubTime":"2026-03-13 18:50","pubTimestamp":1773399059,"startTime":"0","endTime":"0","summary":"中恒集团(600252.SH)公告称,公司董事刘龙因工作安排原因,提请辞去公司董事及董事会相关专门委员会委员等职务,辞职报告自送达董事会之日起生效。刘龙辞职不会导致董事会及审计委员会成员人数低于法定最低人数,亦不存在应履行而未履行的承诺事项。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300033320.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0015","BK0028","BK0239","BK0012","600252","BK0077","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618180767","title":"中恒集团(600252.SH)控股子公司拟出资500万元参与设立创业投资基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2618180767","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618180767?lang=zh_cn&edition=full","pubTime":"2026-03-12 17:50","pubTimestamp":1773309036,"startTime":"0","endTime":"0","summary":"智通财经APP讯,中恒集团 发布公告,近日,公司控股子公司莱美药业与西安沃杰私募基金管理有限公司、圣湘生物科技股份有限公司、广州天使投资母基金创业投资合伙企业、上海皓元医药股份有限公司、北京赛赋医药研究院有限公司、聚智先导(上海)生物科技有限公司和博亚百莱(天津)企业管理咨询中心签署了《广州圣泉百杰创业投资基金合伙企业(筹)之合伙协议》,各方拟共同出资设立圣泉百杰基金。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1413155.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0012","BK0028","600252","BK0077","BK0239","BK0015","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617663316","title":"每周股票复盘:中恒集团(600252)聘任蒋梅芳为副总经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2617663316","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617663316?lang=zh_cn&edition=full","pubTime":"2026-03-08 03:02","pubTimestamp":1772910136,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘,中恒集团报收于2.57元,较上周的2.62元下跌1.91%。本周,中恒集团3月2日盘中最高价报2.61元。广西梧州中恒集团股份有限公司于2026年2月28日发布公告,根据公司实际工作需要,经董事会提名委员会提名,董事会同意聘任蒋梅芳女士担任公司副总经理,任期自董事会审议通过之日起至第十届董事会届满之日止。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030800001040.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600252","BK0015","BK0028","BK0188","BK0012","BK0239","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616835525","title":"中恒集团(600252)披露聘任公司副总经理公告,3月2日股价下跌1.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616835525","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616835525?lang=zh_cn&edition=full","pubTime":"2026-03-02 22:45","pubTimestamp":1772462720,"startTime":"0","endTime":"0","summary":"截至2026年3月2日收盘,中恒集团报收于2.57元,较前一交易日下跌1.91%,最新总市值为81.83亿元。近日,中恒集团发布《关于聘任公司副总经理的公告》。公告显示,2026年2月28日,中恒集团第十届董事会第三十七次会议审议通过聘任蒋梅芳女士为公司副总经理的议案。根据公司实际工作需要,经董事会提名委员会提名,董事会同意聘任蒋梅芳女士担任公司副总经理,任期自董事会审议通过之日起至第十届董事会届满之日止。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200040060.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0015","BK0188","BK0012","600252","BK0077"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778795687136,"stockEarnings":[{"period":"1week","weight":-0.0415},{"period":"1month","weight":-0.0797},{"period":"3month","weight":-0.087},{"period":"6month","weight":-0.2116},{"period":"1year","weight":-0.061},{"period":"ytd","weight":-0.1569}],"compareEarnings":[{"period":"1week","weight":-0.0005},{"period":"1month","weight":0.0376},{"period":"3month","weight":0.0235},{"period":"6month","weight":0.047},{"period":"1year","weight":0.2274},{"period":"ytd","weight":0.0527}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广西梧州中恒集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"118957人(较上一季度增加0.16%)","perCapita":"26767股","listingDate":"2000-11-30","address":"广西壮族自治区梧州市万秀区工业园区工业大道1号第1幢","registeredCapital":"318416万元","survey":" 广西梧州中恒集团股份有限公司的主营业务是医药制造。公司的主要产品是心脑血管领域用药、骨骼肌肉领域用药、其他普药系列、特色专科类、大输液类、抗感染类、其他品种、药品销售服务、医药流通类、龟苓膏系列、龟苓宝系列、其他食品系列。公司荣获华夏医学科学技术奖科技进步奖三等奖、中国中西医结合学会科学技术奖三等奖、广西科技进步奖二等奖各1项,培育1家广西“专精特新”企业,研发综合实力再提升。","listedPrice":5.25},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中恒集团(600252)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中恒集团(600252)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中恒集团,600252,中恒集团股票,中恒集团股票老虎,中恒集团股票老虎国际,中恒集团行情,中恒集团股票行情,中恒集团股价,中恒集团股市,中恒集团股票价格,中恒集团股票交易,中恒集团股票购买,中恒集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中恒集团(600252)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中恒集团(600252)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}